Genome wide association studies (GWAS) and common forms of human epilepsy

Epilepsy and Behavior

Volumn 28, Issue 1, 2013, Pages

  Buono, Russell J ^a  

^a Cooper Medical School of Rowan University ^*  (United States)

Author keywords

Antiepileptic drug (AED) pharmacogenetics; DNA sequencing; Epilepsy susceptibility; Genome wide association

Indexed keywords

ANTICONVULSIVE AGENT; CAMSAP1L1 PROTEIN; DNA; SODIUM CHANNEL NAV1.1; UNCLASSIFIED DRUG;

CHILDHOOD ABSENCE EPILEPSY; CRYPTOGENIC FOCAL EPILEPSY; DNA SEQUENCE; DRUG EFFICACY; DRUG TOLERABILITY; EARLY DIAGNOSIS; EPILEPSY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC GENERALIZED EPILEPSY; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; LARGE SCALE PRODUCTION; MARKER GENE; MULTIPLE SCLEROSIS; MYOCLONUS EPILEPSY; NERVE CELL PLASTICITY; NEXT GENERATION DNA SEQUENCING; PATHOPHYSIOLOGY; PEDIGREE; PHENOTYPE; PUBLICATION; REVIEW; SAMPLE SIZE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ANTICONVULSANTS; EPILEPSY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS;

EID: 84878995535     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.07.006     Document Type: Review

References (9)

1. Visscher P.M., Brown M.A., McCarthy M.I., Yang J. Five years of GWAS discovery. Am J Hum Genet 2012, 90(1):7-24.
2. De Jonghe P. Molecular genetics of Dravet syndrome. Dev Med Child Neurol 2011, 53(Suppl. 2):7-10.
3. Klassen T., Davis C., Goldman A., et al. Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. Cell 2011, 145(7):1036-1048.
4. Genome-wide linkage meta-analysis identifies susceptibility loci at 2q34 and 13q31.3 for genetic generalized epilepsies. Epilepsia 2012, 53(2):308-318. EPICURE Consortium.
5. Kasperaviciūte D., Catarino C.B., Heinzen E.L., et al. Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. Brain 2010, 133(Pt. 7):2136-2147.
6. Guo Y., Baum L.W., Sham P.C., et al. Two-stage genome-wide association study identifies variants in CAMSAP1L1 as susceptibility loci for epilepsy in Chinese. Hum Mol Genet 2011, 21(5):1184-1189.
7. Buono R.J., Helbig I., Zhang H., et al. Identification of epilepsy susceptibility loci by convergence of genome wide association and copy number variation data sets 2010, Society for Neuroscience, [http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=1dfb4638-336e-4544-938e-54c20ae2e4e8&cKey=73347a0d-6950-4b8d-a402-faab516525f7&mKey=[E5D5C83F-CE2D-4D71-9DD6-FC7231E090FB}].
8. Patsopoulos N.A., Bayer Pharma MS Genetics Working Group, Steering Committees of Studies Evaluating IFNβ-1b, et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 2011, 70(6):897-912.
9. Baranzini S.E., Nickles D. Genetics of multiple sclerosis: swimming in an ocean of data. Curr Opin Neurol 2012, 25(3):239-245.